CMPIUnknown
Checkmate Pharmaceuticals, Inc. Insider Trading Activity
Every SEC Form 4 insider transaction reported for Checkmate Pharmaceuticals, Inc. (CMPI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are CMPI insiders buying or selling?
Checkmate Pharmaceuticals, Inc. insiders reported 13 open-market buys ($13.5M) and 8 sells ($15.8M) across 21 Form 4 filings — a net selling position of $2.3M.
Source: SEC EDGAR Form 4
Key Statistics (as of May 17, 2022)
Total Form 4 filings
21
SEC EDGAR
Insider filers
4
Insider buys (13)
$13.5M
Insider sells (8)
$15.8M
Insider sentiment
Net sellingNet insider flow of $2.3M in net selling.
Recent CMPI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| May 17, 2022 | Corey S Goodman | 10% Owner | Sale | 131.7K | $10.45 | $1.4M |
| May 13, 2022 | Corey S Goodman | 10% Owner | Sale | 160.9K | $10.39 | $1.7M |
| May 9, 2022 | Corey S Goodman | 10% Owner | Sale | 86.7K | $10.37 | $898.9K |
| May 4, 2022 | Corey S Goodman | 10% Owner | Sale | 270.7K | $10.38 | $2.8M |
| Apr 29, 2022 | Corey S Goodman | 10% Owner | Sale | 190.0K | $10.38 | $2.0M |
| Apr 26, 2022 | Corey S Goodman | 10% Owner | Sale | 129.8K | $10.39 | $1.3M |
| Apr 22, 2022 | Corey S Goodman | 10% Owner | Sale | 547.7K | $10.41 | $5.7M |
| Feb 25, 2022 | Novo Holdings A/S | 10% Owner | Sale | 8.1K | $2.84 | $23.1K |
| Jun 21, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 7.2K | $6.04 | $43.6K |
| Jun 17, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 3.6K | $6.18 | $22.1K |
| May 19, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 25.0K | $6.97 | $174.3K |
| Apr 1, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 33.2K | $11.16 | $370.7K |
| Mar 29, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 13.5K | $12.30 | $166.3K |
| Jan 28, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 1.7K | $13.05 | $22.2K |
| Jan 21, 2021 | Arthur M Krieg | Chief Scientific Officer | Purchase | 500 | $13.09 | $6.5K |
| Dec 31, 2020 | Arthur M Krieg | Chief Scientific Officer | Purchase | 443 | $14.16 | $6.3K |
| Dec 23, 2020 | Arthur M Krieg | Chief Scientific Officer | Purchase | 5.1K | $14.64 | $74.7K |
| Dec 17, 2020 | Arthur M Krieg | Chief Scientific Officer | Purchase | 4.8K | $14.62 | $70.9K |
| Aug 13, 2020 | Novo Holdings A/S | 10% Owner | Purchase | 500.0K | $15.00 | $7.5M |
| Aug 13, 2020 | Michael Powell | Director, 10% Owner | Purchase | 133.3K | $15.00 | $2.0M |
| Aug 13, 2020 | Corey S Goodman | 10% Owner | Purchase | 200.0K | $15.00 | $3.0M |
Showing the 21 most recent of 21 Form 4 filings for Checkmate Pharmaceuticals, Inc..
Most active CMPI insiders
- Arthur M Krieg10 filings
- Corey S Goodman8 filings
- Novo Holdings A/S2 filings
- Michael Powell1 filing
Ask anything about CMPI insider activity
Use Trabud's AI agent to query Checkmate Pharmaceuticals, Inc.'s Form 4 history in plain English — "Show me CMPI CEO purchases this year" or compare it against any other ticker.
Open the AI agentCMPI insider trading FAQ
Are Checkmate Pharmaceuticals, Inc. insiders buying or selling?
Across 21 SEC Form 4 filings, Checkmate Pharmaceuticals, Inc. (CMPI) insiders reported 13 open-market purchases totaling $13.5M and 8 sales totaling $15.8M. That is a net selling position of $2.3M.
How many insiders trade CMPI stock?
4 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Checkmate Pharmaceuticals, Inc.. The most recent filing was accepted on May 17, 2022.
Where does Trabud get CMPI insider trading data?
All CMPI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.